Post-Acute Withdrawal Syndrome (PAWS): What NYSHIP Members Should Know

By NYSHIP Detox Editorial Team · Published 2026-06-12 · Medically reviewed by Bradley Tourtlotte, MD

Most people know about acute withdrawal — the physical symptoms that emerge in the hours or days after stopping alcohol, opioids, benzodiazepines, or other substances. What is less widely understood is what can follow: post-acute withdrawal syndrome, commonly known as PAWS. For NYSHIP and Empire Plan members in recovery, understanding PAWS can make the difference between interpreting a difficult week as a crisis and recognizing it as a predictable stage of neurological healing.

This article is for general educational purposes only and is not a substitute for professional medical advice. If you are experiencing symptoms that concern you, speak with a qualified healthcare provider. For crisis support, call or text 988 or call the SAMHSA National Helpline at 1-800-662-4357.

What Is Post-Acute Withdrawal Syndrome?

PAWS refers to a cluster of neurological and psychological symptoms that can persist — or appear for the first time — weeks to months after acute detoxification ends. While acute withdrawal reflects the body's immediate chemical adjustment to the sudden absence of a substance, PAWS reflects a longer-term recalibration of brain chemistry, particularly in systems that govern mood, stress response, sleep, and motivation.

According to the National Institute on Drug Abuse (NIDA), addiction causes lasting changes to the brain's reward and stress circuits. These changes do not reverse overnight. The gradual normalization of brain function after sustained abstinence is the biological basis for PAWS — and understanding it as a biological process, rather than a personal failure, is an important part of recovery.

Common Symptoms of PAWS

PAWS presents differently depending on the substance involved and the individual, but frequently reported symptoms include:

• Mood instability: Episodes of anxiety, irritability, depression, or emotional blunting that cycle unpredictably, sometimes without an obvious trigger
• Sleep disturbances: Difficulty falling or staying asleep, restless sleep, or vivid and disturbing dreams that persist well beyond the acute withdrawal phase
• Cognitive difficulties: Trouble concentrating, slowed thinking, memory lapses, and difficulty making routine decisions
• Drug cravings: Powerful urges to use that appear during periods of stress, fatigue, or emotional difficulty
• Fatigue: Persistent low energy even after adequate rest, reflecting the brain's ongoing energy demands during recovery
• Anhedonia: Difficulty experiencing pleasure from activities that used to feel rewarding — a direct consequence of disrupted dopamine function

Symptoms often come in waves rather than being constant. A person may feel well for several weeks, then experience a pronounced low. This unpredictable pattern can feel discouraging, but it is normal. Understanding it in advance reduces the risk of interpreting a difficult week as evidence that recovery is failing.

Which Substances Are Most Associated with PAWS?

PAWS is most thoroughly documented in recovery from:

• Alcohol: The National Institute on Alcohol Abuse and Alcoholism (NIAAA) notes that alcohol-related brain changes can persist for months after abstinence, gradually improving over time with sustained sobriety. Sleep quality, cognitive function, and emotional regulation all tend to recover, though the timeline varies considerably between individuals.
• Opioids: Long-term opioid use reshapes pain and reward processing. PAWS after opioid cessation commonly involves prolonged depression, anxiety, sleep disruption, and intense cravings that may last months.
• Benzodiazepines: Due to the slow normalization of GABA receptor function, benzodiazepine-related PAWS can extend for a year or longer in some individuals. Severe alcohol or benzodiazepine withdrawal requires medical supervision — never attempt to stop these substances without clinical support.
• Stimulants: Stimulant PAWS is characterized primarily by low mood, fatigue, and anhedonia, reflecting the gradual recovery of dopamine and norepinephrine function.

Why PAWS Increases Relapse Risk

PAWS symptoms — especially mood instability, cravings, and sleep disruption — are among the most frequently cited contributors to relapse in early and middle recovery. When someone does not understand that what they are experiencing is a normal stage of healing, they may interpret it as evidence that something is fundamentally wrong, that treatment is not working, or that lasting recovery is not possible for them. This cognitive distortion can drive a return to substance use as a misguided attempt to find relief.

A MedlinePlus resource on alcohol use disorder underscores the importance of ongoing clinical support well beyond the acute withdrawal phase — a key reason why engagement with therapy, peer support, and medical care throughout the PAWS period is strongly recommended rather than optional.

Evidence-Based Strategies for Managing PAWS

While no single medication is approved specifically for PAWS, several approaches have demonstrated real benefit:

• Medication-assisted treatment (MAT): For opioid use disorder, buprenorphine and methadone continue to stabilize brain chemistry and reduce the intensity of PAWS symptoms. For alcohol use disorder, naltrexone and acamprosate may reduce craving and mood instability during this period. Consult a prescriber about whether MAT is appropriate for your situation.
• Cognitive behavioral therapy (CBT): Helps identify and challenge the distorted thoughts that often accompany PAWS episodes, and builds practical coping strategies for managing high-risk periods without returning to use.
• Sleep hygiene: Consistent sleep and wake times, limiting caffeine and screen exposure before bed, and addressing any underlying sleep disorder through a physician can significantly improve PAWS-related sleep disruption.
• Regular aerobic exercise: Growing evidence supports aerobic exercise as an effective intervention for low mood and anhedonia in addiction recovery, helping stimulate dopamine pathways that are recovering during PAWS.
• Peer support: Connection with others who have experienced PAWS normalizes the experience, reduces isolation, and provides practical, lived guidance on navigating difficult periods.

How NYSHIP and the Empire Plan May Cover PAWS-Related Care

If you are a New York State or government employee enrolled in NYSHIP or the Empire Plan, federal mental health parity law requires that ongoing addiction treatment — including outpatient therapy, MAT, and mental health care during the PAWS period — be covered on terms no more restrictive than comparable medical benefits. Your plan should not impose stricter limits on outpatient counseling visits, MAT prescriptions, or psychiatric care than it applies to other medical conditions.

According to the SAMHSA National Helpline (1-800-662-4357), recovery support services — including those that help people navigate PAWS — are an important and effective part of the continuum of care. NYSHIP Detox can help you understand your NYSHIP coverage for ongoing recovery services and connect you with the right level of care.

Getting Help

PAWS is not a sign that recovery has failed. It is a sign that the brain is actively healing — and with the right clinical support and realistic expectations, most people move through this stage and reach sustained stability. If you or a family member is experiencing PAWS symptoms and needs support, call NYSHIP Detox at 213-321-6518 for a free, confidential conversation. You can also reach the SAMHSA National Helpline at 1-800-662-4357 any time, or call or text 988 if you or someone you know is in crisis.

Sources & References

• NIDA — Treatment Research Topics
• NIAAA — Treatment for Alcohol Use Disorder
• SAMHSA — National Helpline
• MedlinePlus — Alcohol Use Disorder (AUD)
• 988 Suicide and Crisis Lifeline